PDB33 COST-CONSEQUENCE ANALYSIS OF SCREENING AND OPTIMIZED TREATMENT OF NEPHROPATHY IN HYPERTENSIVE PATIENTS WITH TYPE-2 DIABETES INA FRENCH SETTING
Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67652-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)67652-8/fulltext
Section Title :
Section Order :
237
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67652-8&doi=10.1016/S1098-3015(10)67652-8